bpc-157 ulcerative colitis phase ii trial BPC-157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven Phase 2 Trial of Anti-TL1A
Description
doi:10.1007/s12603-010-0330-4
Doctors use it for vitamin B deficiency states, peripheral neuropathy, neuritis, nerve pain related to diabetes or alcohol use, and as a supportive therapy during recovery where B1, B6, and B12 are needed
So, when it comes to reconstitution, we consider it an extension of that same philosophy
Accessed 4/16/2021, NIH
In adult humans, about 50 mg/kg of SIgA is produced daily by plasma cells residing in the intestinal lamina propria
